OOIR: Observatory of International Research

Papers

(The median citation count of Therapeutic Advances in Endocrinology and Metabolism is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Role of epicardial adipose tissue in diabetic cardiomyopathy through the lens of cardiovascular magnetic resonance imaging – a narrative review	124
Insulin therapy among diabetic patients in rural communities of Sub-Saharan Africa: a perspective review	114
Gender-affirming hormone therapy, mental health, and surgical considerations for aging transgender and gender diverse adults	60
Effect of sodium-glucose cotransporter-2 inhibitors on patients with essential hypertension and pre-hypertension: a meta-analysis	39
The global burden of thyroid cancer in high-income Asia-Pacific: a systematic analysis of the Global Burden of Disease study	33
Controversies in the management of active Charcot neuroarthropathy	29
Treatment of osteoporosis in the solid organ transplant recipient: an organ-based approach	26
In-person and virtual multidisciplinary intensive lifestyle interventions are equally effective in patients with type 2 diabetes and obesity	24
Novel therapeutic targets for metabolism-related diseases: proteomic Mendelian randomization and colocalization analyses	22
Differences in adherence to using removable cast walker treatment during daytime and nighttime weight-bearing activities in people with diabetes-related foot ulcers	22
Epidemiology, natural history, and diagnosis of metabolic dysfunction-associated fatty liver disease: a comparative review with nonalcoholic fatty liver disease	21
Glycaemic outcomes in people living with diabetes under 65 and over 65 years old using an intermittently scanned continuous glucose monitoring system	21
Update on genetics and epigenetics in metabolic associated fatty liver disease	20
Effectiveness of open-source Android artificial pancreas systems for glucose management in patients with type 1 diabetes: a real-world study	18
Is there a causal relationship between hypothyroidism and hyponatremia?	17
Chronic kidney disease combined with metabolic syndrome is a non-negligible risk factor	17
Design and rationale for the SIB trial: a randomized parallel comparison of semaglutide versus placebo on intestinal barrier function in type 2 diabetes mellitus	17
Pheochromocytoma: a changing perspective and current concepts	17
Diagnostic performance of morning basal serum cortisol for assessing adrenal reserve: a single-center experience from the United Arab Emirates	16
Prevalence and associated factors of hyperuricemia among Chinese patients with diabetes: a cross-sectional study	16
Risk factor management over two decades in hospitalised patients with chronic limb-threatening ischaemia with and without diabetes mellitus	15
Retraction notice	15
A study looking at how missed somatropin injections affect growth in children with growth hormone deficiency: a plain language summary of publication	15
Management strategies for patients with insulin allergy at risk of acute complications: experience from a case report	15
The legacy effect of early HbA1c control on microvascular complications and hospital admissions in type 2 diabetes: findings from a large UK study	15

Role of estrogen in the regulation of central and peripheral energy homeostasis: from a menopausal perspective	15
Limitation of the current Lin-Weiss-Bisceglia criteria in predicting poor prognosis in oncocytic adrenocortical neoplasms of uncertain malignant potential and oncocytoma diagnosed by the Lin-Weiss-Bis	14
Influence of the occurrence and duration of partial remission on short-term metabolic control in type 1 diabetes: the DIABHONEY pediatric study	13
Potential of duodenal mucosal resurfacing in achieving glycemic control in Asians with type 2 diabetes	13
The role of supporting and disruptive mechanisms of FT3 homeostasis in regulating the hypothalamic–pituitary–thyroid axis	13
Gender-affirming endocrine care for youth with a nonbinary gender identity	13
Temporal patterns of inpatient hypoglycaemia are treatment-dependent	12
Immune cell infiltration in the pancreas of type 1, type 2 and type 3c diabetes	12
Bone health in transgender people: a narrative review	12
The missing piece in post-transplant bone health: tertiary hyperparathyroidism management	12
Thanks to Reviewers	11
Analysis of vitamin D nutritional status and disease risk factors in patients with subacute thyroiditis	11
Implications of gender-affirming endocrine care for sports participation	11
Comparing quality of life in traditional face-to-face visits with a hybrid approach of telemedicine with in-person follow-ups in recent users of advanced closed-loop systems: a randomized controlled c	11
Exploring the weight bias of professionals working in the field of obesity with a mobile IAT: a pilot study	11
Therapeutic potential of adiponectin in prediabetes: strategies, challenges, and future directions	10
The bidirectional impacts of alcohol consumption and MAFLD for progressive fatty liver disease	9
Glycogen storage disease type III: a mixed-methods study to assess the burden of disease	9
Timing of osteoporosis therapies following fracture: the current status	9
Age-related markers and predictors of diabetic kidney disease progression in type 2 diabetes patients: a retrospective cohort study	9
Effect of bicalutamide on serum total testosterone concentration in transgender adults: a case series	8
The impact of socioeconomic factors, social determinants, and ethnicity on the utilization of glucose sensor technology among persons with diabetes mellitus: a narrative review	8
Physical activity among adults with type 2 diabetes mellitus in Jordan: a qualitative study	8
Association of body mass index and sarcopenia with osteoporosis: a predictive nomogram model for risk assessment	8
Qualitative evaluation of the symptoms and quality of life impacts of long-chain fatty acid oxidation disorders	8
Analyzing and evaluating the prevalence and metabolic profile of lean NAFLD compared to obese NAFLD: a systemic review and meta-analysis	7
Lipid ratios and obesity indices are effective predictors of metabolic syndrome in women with polycystic ovary syndrome	7
Multi-omics investigation of prospective therapeutic targets for type 1 diabetes	7
The association between diabetes mellitus and incidence of depressive episodes is different based on sex: insights from ELSA-Brasil	7
Multi-target gene therapy AUP1602-C to improve healing and quality of life for diabetic foot ulcer patients: a phase I, open-label, dose-finding study	7
Metabolic-associated fatty liver disease and pregnancy complications: new challenges and clinical perspectives	7
Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes	7
Association of hyponatremia with bone mineral density and fractures: a narrative review	7
Association of serum parathyroid hormone within normal range with the prevalence and prognosis among adults with diabetes and prediabetes: insight from NHANES 2003–2006 data	6
RANKL inhibition: a new target of treating diabetes mellitus?	6
Successful management of hypercalcemic crisis by continuous renal replacement therapy with regional citrate anticoagulation and surgery: a case report	6
A database study of the safety and effectiveness of daily growth hormone in treating more than 80,000 children with growth disorders worldwide: a plain language summary of publication	6
COVID-19 and the hidden threat of diabetic microvascular complications	5
Relationship between total testosterone, sex hormone–binding globulin levels and the severity of non-alcoholic fatty liver disease in males: a meta-analysis	5
Noninsulin antidiabetic prescription patterns in Colombia: a cross-sectional study	5
Liver Biopsy Handling of Metabolic-Associated Fatty Liver Disease (MAFLD): the Children’s Hospital of Eastern Ontario grossing protocol	5
Response to a low-energy meal replacement plan on glycometabolic profile and reverse cardiac remodelling in type 2 diabetes: a comparison between South Asians and White Europeans	5
Emerging pharmacological treatment options for MAFLD	5
HbA1c changes in the first year post-kidney transplant and associated risk factors in a Saudi cohort	5
Effects of 12-week combined interval running and resistance training on cardiac structure and performance in patients with type 1 diabetes	4
Impact of anti-peptic ulcer disease medications on type 2 diabetes mellitus risk in patients with PUD: a population-based retrospective cohort study	4
Hyponatraemia in patients on immune checkpoint inhibitors	4
Menopause, androgens, and cardiovascular ageing: a narrative review	4
Fractures and dislocations of the foot and ankle in people with diabetes: a literature review	4
MAFLD: what 2 years of the redefinition of fatty liver disease has taught us	4

Dual-basal-insulin regimen for the management of dawn phenomenon in children with type 1 diabetes: a retrospective cohort study	4
Fertility preservation options for transgender and nonbinary individuals	4
Perioperative glycemic status is linked to postoperative complications in non-intensive care unit patients with type-2 diabetes: a retrospective study	4
Global epidemiology and burden of type 2 diabetes in adults aged 55 and older: insights from 1990 to 2021	4
Tolvaptan for the treatment of the syndrome of inappropriate antidiuresis (SIAD)	3
Zoledronic acid sequential to teriparatide may promote greater inhibition of bone resorption than zoledronic acid alone	3
A step-by-step guide for the diagnosis and management of hyponatraemia in patients with stroke	3
Incidence and predictors of hyperglycemic emergencies among adult diabetic patients at public hospitals of Sidama Region and Gedeo Zone, Southern Ethiopia: a survival analysis	3
ANDROID and A/G ratio are correlated with sarcopenia among type 2 diabetes patients	3
Hippo/YAP signaling pathway: a new therapeutic target for diabetes mellitus and vascular complications	3
The impact of technology on impaired awareness of hypoglycaemia in type 1 diabetes	3
Real-world evidence of the use of glucocorticoids for severe COVID-19	3